Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases

Information

  • Research Project
  • 9725449
  • ApplicationId
    9725449
  • Core Project Number
  • Full Project Number
    272201500005I-0-27200007-1
  • Serial Number
  • FOA Number
  • Sub Project Id
  • Project Start Date
    12/15/2017 - 7 years ago
  • Project End Date
    12/14/2018 - 6 years ago
  • Program Officer Name
  • Budget Start Date
    -
  • Budget End Date
    -
  • Fiscal Year
    2018
  • Support Year
  • Suffix
  • Award Notice Date
    -

Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases

The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    N01
  • Administering IC
    AI
  • Application Type
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    107814
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NIAID:107814\
  • Funding Mechanism
    Non SBIR/STTR Contracts
  • Study Section
  • Study Section Name
  • Organization Name
    DYNPORT VACCINE COMPANY, LLC
  • Organization Department
  • Organization DUNS
    014130053
  • Organization City
    FREDERICK
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    217024734
  • Organization District
    UNITED STATES